Multiple benefits impacting trial timelines and related cost with notable reductions in protocol deviations rate, recruitment times, and first patient in.
Online ExclusivesBhausaheb Patil, Head of Business Operations, Decentralized Clinical Trials, IQVIA 10.06.22
Early phase drug development is often defined by speed, but planning is essential to avoid added costs and delays in the later stages of a molecule’s journey.
Mat Minardi and John Mykytiuk, Sterling Pharma Solutions10.03.22
Gains non-exclusive rights to use the CAP Ad platform for the manufacturing of adeno-based vaccines for prophylactic and therapeutic use in infectious diseases.
Project will be funded with federal funds from the National Cancer Institute, National Institutes of Health and Department of Health and Human Services.
Adds two manufacturing facilities and strengthens service offerings in formulation development, sterile ophthalmic, and niche manufacturing technologies.